AWAKE Check: A UK study assessing sleep disorder risk in adults using online and pharmacy-based screening

A prospective observational cross-sectional study assessing risk of insomnia and obstructive sleep apnoea in UK adults using validated screening tools (Insomnia Severity Index, STOP-Bang, and FOSQ-10)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN16640471

Enrollment

5000

Registered

2025-09-30

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia disorder

Interventions

Participants will complete a single web-based survey (JotForm) including validated screening tools: the Insomnia Severity Index (ISI), the STOP-Bang questionnaire for obstructive sleep apnoea risk, an

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older 2. Resident in the United Kingdom 3. Able to access and complete an online survey in English 4. Occupation may include employee or learner/student (18+ years)

Exclusion criteria

Exclusion criteria: 1. Individuals under the age of 18 years 2. Non-UK participants, identified through IP address location at survey entry 3. Incomplete survey responses (missing core outcome data)

Design outcomes

Primary

Measure	Time frame
1. Proportion of participants at high risk of insomnia, measured using the Insomnia Severity Index (ISI; score =15), assessed once at baseline (on survey completion). 2. Proportion of participants at high risk of obstructive sleep apnoea, measured using the STOP-Bang questionnaire (score =5), assessed once at baseline (on survey completion).	—

Secondary

Measure	Time frame
1. Proportion of participants at risk of comorbid insomnia and sleep apnoea (COMISA), defined by ISI score =15 and STOP-Bang score =3, assessed once at baseline (on survey completion). 2. Functional impairment due to sleepiness, measured using the Functional Outcomes of Sleep Questionnaire (FOSQ-10), assessed once at baseline (on survey completion). 3. Comparison of sleep disorder risk prevalence across subgroups (occupation, sex, BMI, recruitment channel, and geographic region), assessed once at baseline (on survey completion). 4. Geographic distribution of risk categories, analysed by the first three digits of participant postcodes, assessed once at baseline (on survey completion).	—

Measure

Time frame

1. Proportion of participants at risk of comorbid insomnia and sleep apnoea (COMISA), defined by ISI score =15 and STOP-Bang score =3, assessed once at baseline (on survey completion). 2. Functional impairment due to sleepiness, measured using the Functional Outcomes of Sleep Questionnaire (FOSQ-10), assessed once at baseline (on survey completion). 3. Comparison of sleep disorder risk prevalence across subgroups (occupation, sex, BMI, recruitment channel, and geographic region), assessed once at baseline (on survey completion). 4. Geographic distribution of risk categories, analysed by the first three digits of participant postcodes, assessed once at baseline (on survey completion).

—

Countries

England, United Kingdom

Contacts

Public ContactAdrian Zacher

hello@bspss.org+44 (0)7769187168

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026